SOUTH SAN FRANCISCO, Calif., March 31, 2009 (GLOBE NEWSWIRE) -- Hana Biosciences Inc., (Nasdaq:HNAB), a biopharmaceutical company focused on developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care, today announced financial results for the fourth quarter and the year ended December 31, 2008. The Company also highlighted important clinical development progress and operational highlights from the year 2008.
